Navigation Links
Alzheimer's Drug Discovery Foundation Funds Abiant, Inc. to Develop a Positron Emission Tomography (PET) Imaging Diagnostic for Alzheimer's Disease
Date:9/9/2009

NEW YORK, Sept. 9 /PRNewswire-USNewswire/ -- The Alzheimer's Drug Discovery Foundation (ADDF) announced today that it is providing a grant of $200,000 to Abiant, Inc. (Deerfield, IL), for the development of a highly accurate imaging diagnostic for Alzheimer's Disease. Abiant, a privately held company, is dedicated to the application of neuroimaging to improve the diagnosis and treatment of neurologic and neuropsychiatric disorders.

Abiant's diagnostic approach combines key advances in the analysis of Positron Emission Tomography (PET) images of the brain. The first of these was developed by Lisa Mosconi, PhD, Henry Rusinek, PhD, and Wai Tsui, PhD at the NYU School of Medicine's Center for Brain Health, directed by Mony de Leon, PhD. This advance allows the precise, automated measurement of glucose metabolism in the hippocampus, a brain structure that is critical to new memory formation and which is affected very early in Alzheimer's disease. Abiant is combining this with other key advances in statistical analysis tools that consolidate information from many regions in the brain into measurable patterns of disease progression. In studies using patients from academic centers worldwide, these approaches have been able to predict future decline, and to distinguish between types of dementia with very high accuracy.

"Abiant's diagnostic approach provides a potential path to clinician adoption and use of a powerful aid in early, accurate diagnosis that has not yet been achieved," says Howard Fillit, MD, ADDF's Executive Director. "The grant will enable Abiant to further validate and translate its approaches toward a beneficial tool for the Alzheimer's disease community."

"We are very pleased that ADDF is helping to fund our development efforts," comments Dawn Matthews, Chief Executive Officer of Abiant. "Not only will this help to accelerate our progress, but the ADDF w
'/>"/>

SOURCE Alzheimer's Drug Discovery Foundation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Alzheimers Research Target May Be a Dead End
2. Aging Science Leaders to Gather During Active Aging Week to Encourage Discovery in Healthy Living and Longevity
3. Genetic Discovery May Improve Hepatitis C Treatment
4. New discovery brings hope to treatment of lymphatic diseases
5. Immune System Gene Discovery Sheds Light on Staph Infections
6. Cell Discovery May Bring Science Closer to Diabetes Cure
7. The Psychology of Frailty: An Identity Crisis Among the Elderly - Alzheimers Drug Discovery Foundations Dr. Howard Fillit to Co-Chair Symposium
8. Toronto researchers discovery points to a new treatment avenue for acute myeloid leukemia
9. Scientists Gather to Discuss Novel Uses of Caliper Life Sciences Discovery Platforms and Technology
10. Discovery Points to Regulation of Calcium Metabolism
11. IDRI Awarded $314,500 Grant From Murdock Trust to Expand TB Drug Discovery Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... (PRWEB) October 25, 2014 Background: , ... Recovery (CCAR). He is a pioneer in the field of ... in Connecticut's state treatment system and when he retired, he ... him while in public service. , 1. ... critical decisions concerning them? , 2. Can the recovery ...
(Date:10/25/2014)... 25, 2014 Market Research ... Industry, 2009-2019 is a professional and in-depth ... Diagnostics industry. The report firstly reviews the ... classification, application and manufacturing technology. The report ... of Molecular Diagnostics listing their product specification, ...
(Date:10/25/2014)... 2014 The federal judge overseeing ... ) filed against Boston Scientific Corp. in the ... Southern District of West Virginia has denied a ... in a group of cases filed on behalf ... October 21st, U.S. District Judge Joseph R. Goodwin ...
(Date:10/25/2014)... Oct. 24, 2014 (HealthDay News) -- Interrupting blood supply to ... reduce the risks associated with the surgery, according to a ... stop the blood supply to the heart to be able ... the heart will reduce its ability to produce energy because ... flow to another large muscle, such as an arm or ...
(Date:10/25/2014)... Researchers who discovered antibiotics in farmed and wild ... The use of antibiotics in animals, including ... to the development of antibiotic-resistant bacteria that threaten ... study. Each year in the United States, ... kill about 23,000, according to the Infectious Diseases ...
Breaking Medicine News(10 mins):Health News:CCAR Accepting Nominations for the Bob Savage Recovery Advocate of the Year Award 2Health News:Global and China Molecular Diagnostics Industry Analysis to 2019 is Now Available at RnRMarketResearch.com 2Health News:Global and China Molecular Diagnostics Industry Analysis to 2019 is Now Available at RnRMarketResearch.com 3Health News:Global and China Molecular Diagnostics Industry Analysis to 2019 is Now Available at RnRMarketResearch.com 4Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 3Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 4Health News:Brief Interruption of Blood Supply to Limb Might Aid Heart Surgery: Study 2Health News:Researchers Say Antibiotics in Fish a Health Concern 2
... ... ... Dozier Internet Law, P.C. has filed a lawsuit (Case No. CGC-10-499227) on behalf of ... San Francisco, against Yelp! Inc. The lawsuit alleges that Yelp! has been operating an ...
... Abstract 35P: Markers for risk of pregnancy-associated breast ... child-birth to the third and fourth decades, the ... rise. This paper suggests that identification of p53 ... outbreak or early detection of pregnancy-associated breast cancer. ...
... as epigenetic modifications, regulate the activity of many ... often inactivates important cellular growth brakes. Therefore, this ... major cause of uncontrolled division of cancer cells. ... methylation. Unlike changes in the blueprint ...
... one wants antibiotic residues in their milk. But antibiotics are ... conducted nowadays take hours to produce a result and do ... can now be closed, thanks to a fully automated minilab ... LMU Muenchen and gwk Praezisionstechnik GmbH. Even at ...
... had previous sprain, study says , FRIDAY, May 7 ... in female high school volleyball players, a new study ... players (59.3 percent female, 40.7 percent male) who wore ... and non-rigid) for an entire season and 42 who ...
... contraceptives altered the social and sexual landscape in ways expected ... millions of women have taken it at some point in ... have been arrested for it and it,s still one of ... it,s simply known as "the Pill." , On May 9, ...
Cached Medicine News:Health News:Yelp! Sued Over Alleged Protection Racket 2Health News:Interesting stories at the IMPAKT Breast Cancer Conference 2Health News:Interesting stories at the IMPAKT Breast Cancer Conference 3Health News:Fatty acid to enhance anticancer drug 2Health News:Minilab can quickly identify antibiotic residues in milk, before it leaves the barn 2Health News:Minilab can quickly identify antibiotic residues in milk, before it leaves the barn 3Health News:Ankle Braces May Protect Girl Volleyball Players 2Health News:The Pill Turns 50 2Health News:The Pill Turns 50 3Health News:The Pill Turns 50 4Health News:The Pill Turns 50 5
(Date:10/22/2014)... 2014  Medical Diagnostic Laboratories, L.L.C., (MDL), ... high complexity, state-of-the-art, automated DNA-based molecular analyses, ... Cystic Fibrosis Testing which utilizes cutting edge ... Cystic fibrosis (CF), or mucoviscidosis, ... affects the respiratory, gastrointestinal and reproductive systems. ...
(Date:10/22/2014)... Oct. 22, 2014  Rescheduling of hydrocodone combination ... the pain market, according to a new primary ... firm providing market research and consultation exclusively in ... - http://photos.prnewswire.com/prnh/20141021/153440 In ... hydrocodone combination products from Schedule III to Schedule ...
(Date:10/22/2014)... -- Investor-Edge has initiated coverage on the ... ), Progenics Pharmaceuticals Inc. (NASDAQ: PGNX ), ... Pharmaceuticals Inc. (NASDAQ: IDRA ), and Merrimack ... companies can be accessed at: http://investor-edge.com/register . ... ended at 4,419.48, up 2.40%, the Dow Jones Industrial ...
Breaking Medicine Technology:Medical Diagnostic Laboratories, L.L.C. Institute for Biomarker Research Announces New Prenatal Cystic Fibrosis Tests 2Hydrocodone: Rescheduled, Repositioned & Reinvented 2Hydrocodone: Rescheduled, Repositioned & Reinvented 3Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma 2Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma 3Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma 4Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma 5